ArticleBlood advances2024

Spencer A, Moreau P, Mateos M-V, et al. Daratumumab for patients with myeloma with early or late relapse after initial therapy: subgroup analysis of CASTOR and POLLUX. Blood Adv. 2024;8(2):388-398.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.